Literature DB >> 8532073

Theophylline kinetics in peripheral tissues in vivo in humans.

M Müller1, B v Osten, R Schmid, E Piegler, I Gerngross, H Buchegger, H G Eichler.   

Abstract

Several biochemical and cellular effects have been described for methylxanthines under in vitro conditions. However, it is unknown, whether threshold concentrations required to exert these effects are attained in target tissues in vivo. We therefore employed the microdialysis technique for measuring theophylline concentrations in peripheral tissues under in vivo conditions. Following in vitro and in vivo calibration, microdialysis probes were inserted into the medial vastus muscle and into the periumbilical subcutaneous adipose layer of healthy volunteers. Following single oral dose administration of 300 mg or i.v. infusion of 240 mg theophylline, in vivo time courses of theophylline concentrations were monitored in tissues and plasma. Major pharmacokinetic parameters (cmax, tmax, AUC) were calculated for plasma and tissue time courses. The mean AUCtissue/AUCplasma-ratio was 0.56 (p.o.) and 0.55 (i.v.) for muscle and 0.55 (p.o.) and 0.72 (i.v.) for subcutaneous adipose tissue. We conclude that microdialysis provides important information on the distribution and the tissue pharmacokinetics of theophylline.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532073     DOI: 10.1007/bf00172782

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Measurements by microdialysis of free tissue concentrations of propranolol.

Authors:  P Lönnroth; J Carlsten; L Johnson; U Smith
Journal:  J Chromatogr       Date:  1991-08-23

2.  Drug distribution studies with microdialysis. III: Extracellular concentration of caffeine in adipose tissue in man.

Authors:  L Ståhle; P Arner; U Ungerstedt
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

3.  The use of microdialysis for the determination of plasma protein binding of drugs.

Authors:  S Sarre; K Van Belle; I Smolders; G Krieken; Y Michotte
Journal:  J Pharm Biomed Anal       Date:  1992 Oct-Dec       Impact factor: 3.935

4.  Relationships between pharmacokinetics and nonpulmonary pharmacodynamic effects of theophylline.

Authors:  N A Minton; T S Huseyin; J A Henry
Journal:  Clin Pharmacol Ther       Date:  1994-12       Impact factor: 6.875

5.  Intravenous theophylline-induced excretion of calcium, magnesium and sodium in patients with recurrent asthmatic attacks.

Authors:  R Knutsen; T Bøhmer; J Falch
Journal:  Scand J Clin Lab Invest       Date:  1994-04       Impact factor: 1.713

6.  Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophylline.

Authors:  S Vozeh; G Kewitz; A Perruchoud; M Tschan; C Kopp; M Heitz; F Follath
Journal:  Am Rev Respir Dis       Date:  1982-02

7.  Application of microdialysis to clinical pharmacokinetics in humans.

Authors:  M Müller; R Schmid; A Georgopoulos; A Buxbaum; C Wasicek; H G Eichler
Journal:  Clin Pharmacol Ther       Date:  1995-04       Impact factor: 6.875

8.  Application of microdialysis to the pharmacokinetics of analgesics: problems with reduction of dialysis efficiency in vivo.

Authors:  C Sauernheimer; K M Williams; K Brune; G Geisslinger
Journal:  J Pharmacol Toxicol Methods       Date:  1994-11       Impact factor: 1.950

9.  Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trial.

Authors:  N Holford; P Black; R Couch; J Kennedy; R Briant
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

10.  Effect of phosphodiesterase inhibition with amrinone or theophylline on lipolysis and blood flow in human adipose tissue in vivo as measured with microdialysis.

Authors:  P Arner; J Hellmér; E Hagström-Toft; J Bolinder
Journal:  J Lipid Res       Date:  1993-10       Impact factor: 5.922

View more
  5 in total

Review 1.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

Review 2.  Pharmacokinetic and metabolism studies using microdialysis sampling.

Authors:  D K Hansen; M I Davies; S M Lunte; C E Lunte
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

3.  Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro.

Authors:  A J Chesi; T W Stone
Journal:  Exp Brain Res       Date:  1997-02       Impact factor: 1.972

4.  Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans.

Authors:  M Müller; O Haag; T Burgdorff; A Georgopoulos; W Weninger; B Jansen; G Stanek; H Pehamberger; E Agneter; H G Eichler
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

5.  Applicability of free drug hypothesis to drugs with good membrane permeability that are not efflux transporter substrates: A microdialysis study in rats.

Authors:  Chun Chen; Hongyu Zhou; Chi Guan; Huanhuan Zhang; Yingying Li; Xue Jiang; Zheng Dong; Yuanyuan Tao; Juan Du; Shuyao Wang; Teng Zhang; Na Du; Junyang Guo; Yaqiong Wu; Zehai Song; Haofei Luan; Yu Wang; Hongwen Du; Shaofeng Zhang; Chen Li; Hang Chang; Tao Wang
Journal:  Pharmacol Res Perspect       Date:  2020-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.